MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of July 16, 2026, MXCT trades at $1.41 with a market cap of $152.11M and a P/E ratio of -3.85. MXCT moved +0.35% today. Year to date, MXCT is -8.39%; over the trailing twelve months it is -32.70%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is strong buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for MXCT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.41 |
| Market Cap | $152.11M |
| P/E Ratio | -3.85 |
| EPS | $-0.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.20 |
| 52-Week Low | $0.64 |
| Volume | 1.28M |
| Avg Volume | 0 |
| Revenue (TTM) | $32.29M |
| Net Income | $-39.12M |
| Gross Margin | 80.51% |
4 analysts cover MXCT: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.00.